StatStrip Glucose Hospital Meter System — Class I medical device recall Z-3129-2026
Ongoing recall by Nova Biomedical Corporation, reported 2026-09-23, distributed nationwide. A software synchronization/timing issue in the barcode scanning and patient data processing component that cau
| Recall number | Z-3129-2026 |
|---|---|
| Product type | Medical device |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Nova Biomedical Corporation, Waltham, MA, United States |
| Recall initiated | 2026-07-29 |
| Classified | 2026-09-11 |
| Reported by FDA | 2026-09-23 |
| Distributed | Nationwide (US) |
| Countries outside the US | AT, BE, BO, BR, CA, CH, CL, DE, FI, FR, GB, HR, IE, IL, IT, KR, KY, NL, NZ, TH, TR |
| Quantity | 10,941 units |
| Reason classes | device malfunction, software |
| Model numbers | 66739 |
Product
StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.
Reason for recall
A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the prior barcode information remaining displayed on the screen for the current test. When this defect occurs and the operator accepts the incorrectly displayed patient information without recognizing the mismatch, the current patient's glucose result will be incorrectly assigned to the previous patient's medical record and transmitted to the data management system (DMS), and the current patient's medical record will not receive a result, leaving their glucose status unrecorded and their clinical management without the information needed to guide treatment decisions. The previous patient, whose medical record now contains a glucose result that does not belong to them, may receive inappropriate clinical intervention based on that erroneous result, particularly in critically ill patients, neonates, and infants who cannot communicate symptoms or self-treat. The defect also affects QC barcode scanning: if a QC scan triggers the same retention behavior, QC results may be attributed to an incorrect identifier or QC tests may fail without the user recognizing the underlying cause. This defect does not affect the analytical accuracy of glucose measurements.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-3129-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-29. Not affiliated with or endorsed by FDA. Not medical or legal advice.